InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Tiny Gems
Tuesday May 09, 2023 - 1:22 pm

InvestorNewsBreaks — Cepton Inc. (NASDAQ: CPTN), NVIDIA Collaborating to Integrate Leading Lidar Tech into Driving Simulation Platform

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is collaborating with NVIDIA to incorporate its Vista-X120 Plus lidar into DRIVE Sim, an end-to-end simulation platform built on Omniverse. The company noted that the announcement builds on previous integrations of its automotive lidar models that were used for the development of autonomous driving algorithms, sensors and software. In fact, the announcement noted that…

Continue Reading

Tuesday May 09, 2023 - 11:59 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Doses Last Subject in Phase 1, Part B CYB004-E Trial

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, has completed dosing in part b of its three-part CYB004-E phase 1 trial. The study is designed to evaluate intravenous N,N-dimethyltryptamine (“IV DMT”) in healthy volunteers. The company also announced that it now plans to move forward with part C of the study,…

Continue Reading

Tuesday May 09, 2023 - 11:19 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Pricing on Current Public Offering

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced the pricing of its public offering, which consists of 2,106,000 units, with each unit including one share of common stock (or one prefunded warrant to purchase one share of common stock in lieu thereof) and one warrant to purchase one share of common stock. According to the announcement, each until will be available…

Continue Reading

Monday May 08, 2023 - 2:13 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement, the study is the result of the focus Lexaria has had for years on oral nicotine formulations as an alternative to vaping or smoking; the company noted that results from the study could lead to more rapid…

Continue Reading

Friday May 05, 2023 - 1:07 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Inks Stiff Person Syndrome Clinical Trial Agreement with Mayo Clinic

Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, and its subsidiary Adimune(TM) Inc. announced a clinical trial agreement with Mayo Clinic. The clinical trial, which is designed to advance clinical studies targeting autoimmune diseases of the central nervous system (“CNS”), is expected to begin this year with an estimated 10 to 15 patients, some of…

Continue Reading

Thursday May 04, 2023 - 9:55 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Customer Pricing for Two Models, Notes 1-for 25 Reverse Stock Split

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is releasing customer pricing for its Class 1 EV cargo van; the company announced that the starting price for the EV van will be $34,500 and the class 3 EV cab chassis trucks will start at $68,500. The announcement comes as the company has delivered 19 EV cargo vans to date with 20 more planned…

Continue Reading

Thursday May 04, 2023 - 9:00 am

InvestorNewsBreaks – Vision Energy Corp. (VENG) Confirms Current Trading Status

Vision Energy (OTC: VENG) has announced that the OTC Markets Group (“OTC”) removed the “Caveat Emptor” designation from the company’s profile on April 27, 2023. As previously disclosed, the OTC, on Jan. 20, 2023, labeled the company with such designation. The removal indicates that Vision Energy demonstrated to the OTC that there is no longer a public interest concern. As a result, there is now…

Continue Reading

Wednesday May 03, 2023 - 11:00 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Corporate Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on its manufacturing activities in its two facilities and in producing its line of EVS. The company also noted that as of April 30, 2023, it had available cash of $116.1 million and has received $263 million in purchase orders for its Mullen class 1 and class 3 EV vans and trucks from…

Continue Reading

Monday May 01, 2023 - 11:12 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Receives Follow-Up Fleet Order from UNC Charlotte

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received a second order of eight EV campus cargo vans from the University of North Carolina at Charlotte (UNC Charlotte). The campus vans offer 186 miles of range and are designed for closed campus use, featuring the same DNA as the Mullen ONE class 1 EV cargo van but purpose-built to be an ideal…

Continue Reading

Monday May 01, 2023 - 10:00 am

InvestorNewsBreaks – Vision Energy Corp. (VENG) Issues Corporate and Project Development Update

Vision Energy (OTC: VENG) has provided a corporate and project development update. Among the results for the fiscal year ended Dec. 31, 2022, the company highlighted its sale of VoltH2 Dutch Subsidiaries, resulting in $11.25 MM injection of cash from sale proceeds to paid in capital as part of stockholders’ equity, as well as the acquisition of Evolution Terminals B.V. inclusive of 14 H.A. In…

Continue Reading

Friday Apr 28, 2023 - 10:33 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on EMM Installation in Nation’s Capital, Recent Stock Performance

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has provided an update on the testing and installation of Energy Management Modules (“EMM”) comprised of 40 Chevrolet Bolts within the Washington, DC, city government’s vehicle fleet. According to the update, Mullen Advanced Energy Operations (“MAEO”) has been collaborating on the testing; MAEO is a 51%-owned subsidiary of Mullen Automotive EV Technologies LLC and Global…

Continue Reading

Tuesday Apr 25, 2023 - 12:45 pm

InvestorNewsBreaks – Freight Technologies Inc.’s (NASDAQ: FRGT) Fr8App Named BeatBox’s No. 1 Carrier for Cross Border Shipments

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning, offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region. The company today announced that its Fr8App was named BeatBox Beverages’ number one carrier for cross-border shipments. “At Fr8Tech, we are committed to providing our clients with the best…

Continue Reading

Tuesday Apr 25, 2023 - 10:15 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on $1.9M Registered Direct Offering

Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced that it has closed on its previously announced registered direct offering. The company transacted the closing with a single healthcare-focused institutional investor; the closing consisted of the purchase and sale of 1,585,350 shares of common stock (or common stock equivalents in lieu thereof), which were made…

Continue Reading

Monday Apr 24, 2023 - 1:07 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards CRO Contract for Upcoming Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it awarded the contract for clinical research organization (“CRO”) services to California-based InClin, Inc. for its expected upcoming Food and Drug Administration (“FDA”)-registered, U.S. phase 1b Investigational New Drug (“IND”) hypertension study HYPER-H23-1 with its patented DehydraTECH-powered cannabidiol (“DehydraTECH-CBD”). According to the announcement, HYPER-H23-1 is entitled “A Phase 1b Randomized,…

Continue Reading

Monday Apr 24, 2023 - 10:48 am

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Release of Q1 2023 Earnings Results, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that it will provide a business update and release its financial results for the first quarter of 2023 following the close of the market on Tuesday, May 9, 2023. At 2:30 p.m. PT on that same day, Cepton will hold a conference call and webcast. Interested parties should dial 1-888-886-7786…

Continue Reading

Monday Apr 24, 2023 - 10:27 am

InvestorNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) MAEO to Execute $680K Contract with the District of Columbia

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that its majority owned subsidiary, Mullen Advanced Energy Operations (“MAEO”), will today begin execution of a $680,000 contract that was previously awarded by the District of Columbia, Washington, D.C., to EV Technologies, LLC. The contract covers the purchase and installation of Energy Management Module (“EMM”) units on Chevrolet Bolts within the D.C. city…

Continue Reading

Friday Apr 21, 2023 - 1:48 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently reported the enrollment of the first patient in Switzerland as a participant in its ongoing potentially pivotal global trial evaluating Berubicin for the treatment of glioblastoma multiforme (“GBM”). “CNS Pharmaceutical’s adaptive, multicenter, open-label, randomized controlled study targets adult patients with recurrent GBM after failure of standard first-line therapy. In addition, the study will also enroll patients who have received additional…

Continue Reading

Friday Apr 21, 2023 - 12:45 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Differentiated with Focus on Tech-Driven Solutions, Outstanding Customer Service

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) recently acknowledged an endorsement by leading investment and research firm Chardan Capital Research that included a buy rating for the company at a price target of $2.00. “We are pleased to be able to share the results of Chardan’s independent analysis of our company’s growth and potential. Our focus on technology-driven solutions and outstanding customer service has allowed us to…

Continue Reading

Thursday Apr 20, 2023 - 2:21 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Test Results for Acquired Tech Showing Major Energy Advancement

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released test results from technology acquired through a recent joint venture. According to the announcement, previous vehicle test results, which were performed by Element Materials Technology, show that Energy Management module (“EMM”) technology resulted in range increase of 60%–70% along with an increase in efficiency of any current EV battery. In addition to the…

Continue Reading

Thursday Apr 20, 2023 - 10:39 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expanding Portfolio with Four New Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has received notifications of four new patents either awarded or allowed. In Japan, the company secured a new patent under its Patent Family #3: Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Agents. This is Lexaria’s fifth awarded patent in Japan, providing strength to its growing Japanese patent portfolio. In…

Continue Reading

Thursday Apr 20, 2023 - 9:50 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Inks Asset Purchase Agreement for 50% Ownership of Global Response Aid

Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, has signed an asset purchase agreement with Cellvera Ltd. According to the announcement, the agreement gives Aditxt a 50% ownership in G Response Aid FZE; the remaining 50% ownership belongs to global logistics leader Agility Inc. Calling the agreement a “significant step” for the company, Aditxt officials…

Continue Reading

Wednesday Apr 19, 2023 - 11:30 am

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Expands Proprietary Chipset for Automotive Lidar with Release of Komodo

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced the release of Komodo, its proprietary lidar point cloud processor ASIC (Application-Specific Integrated Circuit) chip. A highly integrated custom SoC, developed by Cepton in California, Komodo is designed to maximize the technical advantages of Cepton’s patented lidar architecture to significantly improve point cloud quality while replacing several merchant silicon devices…

Continue Reading

Tuesday Apr 18, 2023 - 10:16 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN), EVT Collaborate to Enhance EV Performance, Scale to Other Energy Applications

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a partnership with Global EV Technology, Inc. and EV Technologies, LLC. (collectively “EVT”) to form Mullen Advanced Energy Operations, LLC. (“MAEO”) with initial development for improving energy management technology in electric vehicles for greater range and vehicle performance and scaling to other energy applications. Mullen owns 51% of the newly formed entity and…

Continue Reading

Tuesday Apr 18, 2023 - 10:10 am

InvestorNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Releases Financial Report for Q4, FY 2022

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, is reporting record full-year revenues in its just-released financial report, which covers the fourth quarter and full year for the period ending Dec. 31, 2022. Highlights of the report included 33% growth in full-year revenue, which totaled $32.9 million on processing volume…

Continue Reading

Monday Apr 17, 2023 - 10:28 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Shareholder Update on Major Programs, M&A Plans

Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has released a shareholder update outlining its three innovation programs and strategic M&A initiatives. The update notes that subsidiary Pearsanta submitted a bid to acquire substantially all assets of Lucira Health Inc., including Lucira Connect and FDA-approved at-home combination COVID-19 and flu tests. The company was…

Continue Reading

Monday Apr 17, 2023 - 10:05 am

InvestorNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Plans to Release Q4, FY 2022 Financial Report Later Today

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, announced that it will release financial information later today. The financial report will for the fourth quarter and full year 2022. In addition, the company noted that it has scheduled an earnings call, which will begin at 4:30 p.m. ET today. During…

Continue Reading

Friday Apr 14, 2023 - 12:52 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Positive Results in First Diabetes Study

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is increasing the bioavailability of and improving the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery with its patented DehydraTECH(TM). “Most recently, a company announcement indicates that a just-completed DIAB-A22-1 diabetes study has produced at least three positive outcomes, including weight loss in obese diabetic-conditioned animals…

Continue Reading

Thursday Apr 13, 2023 - 12:00 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Receives NASDAQ Notification, Has Regained Compliance

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process, has regained compliance with NASDAQ listing requirement. The company received written notification in October 2022 that it no longer complied with NASDAQ’s minimum bid price requirement for continued listing on the Nasdaq Capital Market; the reason for the notification was the company’s closing bid price ordinary shares had…

Continue Reading

Thursday Apr 13, 2023 - 11:42 am

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Unveils Ultra-Slim, High Performance Automotive Lidar – the Vista(R)-X90 Plus

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, today announced the unveiling of its record-breaking new lidar, Vista(R)-X90 Plus. Expanding on the design innovation of Cepton’s recently introduced Vista(R)-X120 Plus, Vista-X90 Plus becomes the world’s smallest high-performance automotive lidar with software definable perception capabilities. The lidar’s extremely compact size and minimal height enables seamless integration behind the windshield and in other locations…

Continue Reading

Monday Apr 10, 2023 - 1:06 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls Over 100 Patients in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that more than 100 patients have been enrolled in the company’s potentially pivotal study with its lead product candidate, Berubicin. “We have long promised a study with a robust sample size sufficient to effectively determine Berubicin’s therapeutic…

Continue Reading

Thursday Apr 06, 2023 - 12:30 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Notes Record Number of New Shipper Clients Onboarded in March

Freight Technologies (NASDAQ: FRGT), a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform that offers a B2B cloud-based solution for cross-border and domestic shipping within the USMCA region, saw a record increase in the number of new shipper clients added during March 2023. The company reported that the increase comes after a “challenging first quarter” and include clients from an array of sectors, including…

Continue Reading

Thursday Apr 06, 2023 - 12:28 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Adds Italy to Growing Portfolio of Countries for Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP) today announced its receipt of approval from the Italian Medicines Agency (“AIFA”) Competent Authority and the A.O.U. Policlinico di Bari Ethics Committee for its ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. According to the update, the company plans to open its clinical sites in Italy…

Continue Reading

Thursday Apr 06, 2023 - 11:35 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces New Sales, Security Robot Deployment

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, received three new purchase orders for its K1 emergency communication systems. The company also deployed another K5 ASR at a healthcare facility. This growth is symbolic of the company’s growing momentum and increasing sales in an array of sectors. The K1 orders came from VIA Metro Transit of…

Continue Reading

Wednesday Apr 05, 2023 - 10:07 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Achieves 10-Year Milestone, Announces NYC Roadshow Stop

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is celebrating its 10-year anniversary. As part of the celebration, the company is recommitting to its mission of making the United States the safest country in the world by helping to protect the places people live, work, study and visit. The company has scheduled upcoming town halls for a…

Continue Reading

Tuesday Apr 04, 2023 - 10:00 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Completion of Pilot Program at LAX; Accelerates Integration of New Battery Tech

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has successfully concluded a 60-day commercial EV pilot program with Menzies Aviation and Loop Global Inc. at the Los Angeles International Airport (“LAX”). Menzies currently operates in 250-plus airports in 58 countries to provide ground, air cargo and fuel services to commercial airports and airlines. During the pilot program, Menzies used two class 1 EV vans at…

Continue Reading

Monday Apr 03, 2023 - 3:18 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Provides Foundation for Improving Effectiveness of Lipophilic Drugs, APIs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is positioned for opportunity with its patented DehydraTECH(TM) technology and its wide-reaching potential. “Lexaria’s DehydraTECH is designed to formulate and deliver lipophilic (fat-soluble) drugs and active pharmaceutical ingredients (‘APIs’). DehydraTECH increases the effectiveness of and improves the way APIs enter the bloodstream. The benefits of consuming a DehydraTECH-enabled drug or product include: speed…

Continue Reading

Monday Apr 03, 2023 - 10:18 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Notes Delivery of Class 1 EV Cargo Vans to UNC Charlotte, ‘First of Many’ Expected Orders

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced the delivery of Class 1 EV cargo vans to the University of North Carolina at Charlotte (“UNC Charlotte”); Randy Marion Automotive Group facilitated the delivery of the EV vehicle. According to the announcement, the university, which is committed to helping create a more sustainable environment, plans to use the MULN cargo vans for a variety of…

Continue Reading

Friday Mar 31, 2023 - 12:47 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Delivery of First-Class 1 EV Cargo Vans to North Carolina Leasing Company

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has successfully delivered class 1 EV cargo vans to MGT Company (“MGT”) in Highpoint, North Carolina; the order was fulfilled by the Randy Marion Automotive Group. According to the announcement, MGT as one of Mullen’s first commercial EV fleet customers. A growing commercial vehicle sales and leasing company reporting 2022 revenue of more $70 million,…

Continue Reading

Wednesday Mar 29, 2023 - 12:07 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Secures Hospital Contract Renewal for Seventh Year

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced that a long-time healthcare client has renewed its K5 Autonomous Security Robot (“ASR”) contract for the seventh consecutive year. The announcement reads, "The client’s ASR patrols a Southern California hospital parking lot to help protect the property, healthcare providers, patients, visitors and their vehicles. By doing so,…

Continue Reading

Tuesday Mar 28, 2023 - 11:38 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Files Lawsuit for Damages Sustained from False Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has filed a civil complaint for defamation in the Superior Court of Delaware. The complaint alleges that on March 22, 2023, Intersection Media Group, d/b/a dot.LA, published an article on its website authored by David Shultz that contained false and defamatory statements regarding Mullen, including false and defamatory statements regarding the…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).